AVP and cancer: Harrington et al. [11] developed machine learning models to predict ADH upgrade in 128 biopsy specimens and concluded that the most important predictors for upgrade status were patient age, size of lesion, number of biopsies, and personal and family history of cancer; however, they did not evaluate imaging features for inclusion into their models.